These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. Yang SC; Hillinger S; Riedl K; Zhang L; Zhu L; Huang M; Atianzar K; Kuo BY; Gardner B; Batra RK; Strieter RM; Dubinett SM; Sharma S Clin Cancer Res; 2004 Apr; 10(8):2891-901. PubMed ID: 15102698 [TBL] [Abstract][Full Text] [Related]
5. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461 [TBL] [Abstract][Full Text] [Related]
6. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Kirk CJ; Hartigan-O'Connor D; Nickoloff BJ; Chamberlain JS; Giedlin M; Aukerman L; Mule JJ Cancer Res; 2001 Mar; 61(5):2062-70. PubMed ID: 11280767 [TBL] [Abstract][Full Text] [Related]
19. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes. Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660 [TBL] [Abstract][Full Text] [Related]
20. Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice. Warren P; Song W; Holle E; Holmes L; Wei Y; Li J; Wagner T; Yu X Anticancer Res; 2002; 22(2A):599-604. PubMed ID: 12014627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]